Bipolar Transurethral Enucleation Versus Resection in the Treatment of Benign Prostatic Hyperplasia: a Comparative Study
Benign prostatic hyperplasia (BPH) is a common chronic progressive disease resulting in the enlargement of the prostate gland and bladder outlet obstruction in aging men .

Because of the increasing aged population and advancements in diagnostic tools, the incidence and importance of BPH have increased . BPH can be treated either with watchful waiting, drug therapy, or surgery being the most effective treatment option for BPH .

Transurethral resection of the prostate (TURP) has been recognized as the standard treatment for BPH with morbidity rate varies from 18% and 26% Until now, only open prostatectomy and transurethral Holmium laser enucleation of the prostate (HoLEP) have shown an equal efficacy and durability compared to TURP
- EligibilityCriteria: Inclusion Criteria:  all patients with symptomatizing BPH who have a prostate volume > 60 gm and indicated for surgical treatment.  Exclusion Criteria:  patients with small fibrotic prostates, high PSA (not co-inciding with BPH), neurogenic bladder. - HealthyVolunteers: Accepts Healthy Volunteers - Gender: Male - MinimumAge: 50 Years - MaximumAge: 90 Years - StdAgeList: Adult, Older Adult